Biomarkers to guide immunomodulatory treatment: where do we stand?
Evdoxia KyriazopoulouEvangelos J Giamarellos-BourboulisKarolina AkinosoglouPublished in: Expert review of molecular diagnostics (2023)
Targeted immunotherapy has improved outcomes in oncology and rheumatology, paving the way for precision medicine in the critically ill. Transcriptomics will play a crucial role in detecting the most suitable candidates for immunomodulation.